JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 35 No. 10 1618-1623
© 1994 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lapela, M.
Right arrow Articles by Joensuu, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lapela, M.
Right arrow Articles by Joensuu, H.

Imaging of Uterine Carcinoma by Carbon-11-Methionine and PET

Maria Lapela, Sirkku Leskinen-Kallio, Matti Varpula, Seija Grenman, Kalle Alanen, Kjell Någren, Pertti Lehikoinen, Ulla Ruotsalainen, Mika Teräs and Heikki Joensuu

Department of Oncology and Radiotherapy, Department of Pathology, and Turku Medical Cyclotron/PET Center, Turku University
Medical Imaging Center and Department of Obstetrics and Gynecology, Turku University Central Hospital, Turku, Finland

Correspondence: For correspondence or reprints contact: Maria Lapela, MD, Department of Oncology and Radiotherapy, Turku University Central Hospital, FIN - 20 520 Turku, Finland.

ABSTRACT

L-[methyl-11C]methionine ([11C)methionine) is probably one of the most useful positron-emitting tracers for metabolic imaging of human cancer. In this study, we investigated whether human uterine cancer can be imaged with [11Cjmethionine and PET. Methods: Fourteen patients with primary uterine malignancy participated in the study. Eight patients had endometrial card noma and six had cervical carcinoma. The normal endometrium was analyzed in four additional patients with no uterine malignancy and in one patient with cervical cancer. Tracer uptake was quantitated by calculating both the Standardized uptake values (SUVs) and the kinetic influx constants (Ki values) for the tracer. Results: All patients with either cervical or endometrial carcinoma had increased uptake of [11C]methionine in the PET image. The mean SUV of the carcinomas was 8.4 (n = 13; s.d., 1.5) and the mean Ki was 0.15 min–1 (n= 12; s.d., 0.08 min–1), whereas the mean SUV of the normal endometrium was only 4.6 (n = 5; s.d., 0.8). Histologically poorly (Grade III) or moderately (Grade II) differentiated endometrial carcinomas accumulated more [11C]methionine than the well-differentiated (Grade I) ones (p = 0.04 for the SUVs, and p = 0.05 for the Ki values). There were also variable physiological accumulations of [11C]methionine in the pelvis. Conclusions: Uterine carcinoma accumulated [11C]methionine more than the normal endometrium. However, the physiological accumulations of [11C]methionine in the pelvis may confuse the interpreter of the PET image; thus, morphological imaging also needs to be performed as a reference to localize the tumor accurately. We conclude that human uterine carcinoma can be effectively imaged with [11C]methionine and PET.

Key Words: PET • methionine • uterine cancer




This article has been cited by other articles:


Home page
JNMHome page
N. Pandit-Taskar
Oncologic Imaging in Gynecologic Malignancies
J. Nucl. Med., November 1, 2005; 46(11): 1842 - 1850.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
P. L. Jager, W. Vaalburg, J. Pruim, E. G.E. de Vries, K.-J. Langen, and D. A. Piers
Radiolabeled Amino Acids: Basic Aspects and Clinical Applications in Oncology
J. Nucl. Med., March 1, 2001; 42(3): 432 - 445.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1994 by the Society of Nuclear Medicine.